GERD (acid reflux) decisions — 2025

The Board remands the claims for service connection for migraine headaches and gastroesophageal reflux disease (GERD) due to pre-decisional duty to assist errors.

The Board remands the claim for service connection for IBS to ensure a proper VA opinion is obtained regarding its direct and secondary causes, including aggravation by service-connected disabilities.

The Board denied the Veteran's claim for an increased rating in excess of 10 percent for hiatal hernia with gastroesophageal reflux disease as the evidence did not show symptoms productive of considerable impairment of health.

The Board remands the claims for service connection for GERD, a stomach condition, bilateral flatfoot, headaches, left and right ankle conditions, and left and right knee conditions due to a pre-decisional duty to assist omission.

The Board granted service connection for obstructive sleep apnea as secondary to the Veteran's service-connected post-traumatic stress disorder, tinnitus, cervical spine, and/or gastroesophageal reflux disease disabilities, and an increase rating of 30 percent for GERD.

The Board dismissed the appeals for a rating in excess of 10 percent for GERD, service connection for left hand and skin disorders, PTSD, and remanded the claim for service connection for a back disorder due to new and relevant evidence being submitted.

The Board remands the claims for service connection for obstructive sleep apnea and a gastrointestinal disorder, to include gastroesophageal reflux disease, as secondary to service-connected disabilities for further development of the record.

The Board denied an increased rating for the Veteran's service-connected GERD, finding that the symptoms did not warrant a higher 30 percent rating.

The Board granted a 30 percent evaluation for left upper extremity radiculopathy, denied an increased rating for right upper extremity radiculopathy, restored the 20 percent rating for cervical spine degenerative disc disease, and granted a total disability rating based on individual unemployability.

The claim for service connection for left ear hearing loss was dismissed due to a procedural defect. The remaining claims were remanded for further development.

The Board granted a rating of 30 percent for the Veteran's gastroesophageal reflux disease (GERD) due to symptoms including recurrent epigastric distress, reflux, vomiting, nausea, and sleep disturbance.

The Board remands the claims for service connection for bilateral lower extremity peripheral neuropathy and GERD with stricture of the esophagus and gastritis to obtain an adequate medical opinion.

The appeal for entitlement to accrued benefits was dismissed, and the claims for service connection were remanded.

The Board denied service connection for gastroesophageal reflux disease (GERD) as there was no evidence that the condition began during active service or is otherwise related to an in-service injury or disease.

The Board denied increased ratings for several conditions, granted an initial rating of 70 percent for bipolar disorder, and remanded other issues.

The Board denied the veteran's claims for increased ratings for various service-connected conditions, including anxiety disorder, diabetes mellitus, obstructive sleep apnea, peripheral neuropathy, and gastroesophageal reflux disease.

The Board denied service connection for tinnitus and remanded the claims for other conditions due to a lack of evidence.

The Board granted service connection for GERD and AFIB, but denied an initial compensable rating for hypertension.

The Board denied increased ratings for multiple service-connected conditions, including tinnitus, GERD with hiatal hernia, major depressive disorder with generalized anxiety disorder, spinal stenosis with lumbosacral strain status post surgery, scars of the back, and radiculopathy in both lower extremities. The Veteran's erectile dysfunction was also denied a compensable rating.

The Board granted service connection for seborrheic dermatitis and actinic keratosis with an effective date of March 13, 2020, and a 10 percent rating. The claim for an earlier effective date for GERD was dismissed, and the TDIU was granted from August 10, 2022.